Literature DB >> 15286968

Prognostic significance of both surgical and pathological assessment of curative resection for rectal cancer.

A Martling1, T Singnomklao, T Holm, L E Rutqvist, B Cedermark.   

Abstract

BACKGROUND: Information on whether surgery has been 'curative' is essential for prediction of prognosis and for selection of patients for adjuvant treatment. The aim of this study was to analyse the prognostic value of surgeons' and pathologists' assessments of tumour clearance in patients with primary rectal cancer who underwent resection.
METHODS: A total of 1550 patients were studied prospectively. Data were collected from reports made by surgeons and pathologists on whether tumour clearance had been 'complete', 'uncertain' or 'incomplete'. The predictive value in relation to outcome after at least 5 years of follow-up was assessed.
RESULTS: In patients assessed as having a complete surgical clearance, tumour recurrence developed in 33.3 per cent. For patients with an uncertain or incomplete clearance the recurrence rate was 59.5 and 61 per cent respectively (P < 0.001). The relative risk of recurrence was twice as high when the surgeon and pathologist disagreed than when they both agreed on the complete clearance. Survival in patients with a complete, uncertain or incomplete surgical clearance was 55.3, 23.0 and 10 per cent respectively (P = 0.050).
CONCLUSION: Assessments of tumour clearance were of strong prognostic value in relation to outcome. When the surgeon or pathologist was uncertain, or there was disagreement about the completeness of clearance, the risk of recurrence was similar to that among patients in whom an incomplete resection had been performed. Copyright 2004 British Journal of Surgery Society Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15286968     DOI: 10.1002/bjs.4557

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer.

Authors:  Shahin Hajibandeh; Shahab Hajibandeh; Mokhtar Eltair; Anil T George; Vijay Thumbe; Andrew W Torrance; Misra Budhoo; Howard Joy; Rajeev Peravali
Journal:  Int J Colorectal Dis       Date:  2020-03-02       Impact factor: 2.571

2.  Occurrence and prognostic value of circumferential resection margin involvement for patients with rectal cancer.

Authors:  Cun Wang; Zong-guang Zhou; Yong-yang Yu; Ye Shu; Yuan Li; Lie Yang; Li Li
Journal:  Int J Colorectal Dis       Date:  2009-01-20       Impact factor: 2.571

Review 3.  Pathologic processing of the total mesorectal excision.

Authors:  Molly Campa-Thompson; Robert Weir; Natalie Calcetera; Philip Quirke; Susanne Carmack
Journal:  Clin Colon Rectal Surg       Date:  2015-03

4.  Impact of Surgical Approach on Surgical Resection Quality in Mid- and Low Rectal Cancer, A Bayesian Network Meta-Analysis.

Authors:  Xiaojie Wang; Zhifang Zheng; Qian Yu; Waleed M Ghareeb; Xingrong Lu; Ying Huang; Shenghui Huang; Shuangming Lin; Pan Chi
Journal:  Front Oncol       Date:  2021-08-11       Impact factor: 6.244

5.  Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.

Authors:  Sapho Xenia Roodbeen; Marta Penna; Hugh Mackenzie; Miranda Kusters; Andrew Slater; Oliver M Jones; Ian Lindsey; Richard J Guy; Chris Cunningham; Roel Hompes
Journal:  Surg Endosc       Date:  2018-10-22       Impact factor: 4.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.